News >

Relapsed Myeloma: With Great Options Comes Great Responsibility

Published: Friday, Aug 09, 2019

Noopur Raje, MD, director, Center for Multiple Myeloma, Massachusetts General Hospital

Noopur Raje, MD

There is no shortage of treatment options for relapsed/refractory multiple myeloma, with the armamentarium set to further expand amid the emergence of BCMA-targeting CAR T-cell therapies and antibody-drug conjugates.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication